Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 3 / Research Article
Postprandial Glucose Levels Are Better Associated with the Risk Factors for Diabetes Compared to Fasting Glucose and Glycosylated Hemoglobin (HbA1c) Levels in Elderly Prediabetics: Beneficial Effects of Polyherbal Supplements—A Randomized, Double-Blind, Placebo Controlled Trial Table 3 Differences in 2h-postprandial glucose levels (2h-PG, mmol/l) between the GlucoVita and placebo subgroups stratified by age, BMI, and metabolic symptoms.
Subgroup Treatment Preintervention Postintervention Change in Value Total GlucoVita (N=43) 8.15±1.67 7.35±2.06 0.76±2.02 Placebo (N=45) 7.94±1.54 7.41±2.11 0.60±1.92 t 0.61 -0.13 0.39 P 0.55 0.90 0.69 AGE Age<=65yrs GlucoVita (N=31) 8.02±1.78 7.10±2.16 0.92±2.00 Placebo (N=30) 7.95±1.6 7.06±1.95 0.99±1.93 t 0.17 0.08 -0.13 P 0.86 0.94 0.90 Age>65yrs GlucoVita (N=12) 8.48±1.37 8.00±1.7 0.36±2.11 Placebo (N=15) 7.93±1.48 8.11±2.31 -0.18±1.71 t 0.99 -0.13 0.73 P 0.33 0.89 0.47 SYMPTOMS No symptoms GlucoVita (N=23) 8.05±1.93 7.06±2.01 0.99±2.16 Placebo (N=24) 7.41±1.41 6.98±1.76 0.42±1.41 t 1.30 0.14 1.06 P 0.20 0.89 0.29 Symptoms present GlucoVita (N=20) 8.27±1.36 7.69±2.12 0.51±1.87 Placebo (N=21) 8.55±1.49 7.90±2.41 0.80±2.4 t -0.64 -0.30 -0.43 P 0.53 0.77 0.67 BMI Normal GlucoVita (N=13) 7.33±1.68 7.05±2.23 0.18±1.91 Placebo (N=12) 7.6±1.11 6.68±1.49 0.93±2.24 t -0.47 0.48 -0.91 P 0.64 0.63 0.37 Overweight GlucoVita (N=20) 8.80±1.51++ 7.20±1.83 1.60±2.12+ Placebo (N=22) 7.53±1.4 7.15±1.82 0.52±1.22 t 2.83 0.10 2.05 P 0.01 0.92 0.05 Obese GlucoVita (N=10) 7.90±1.57 8.05±2.32 -0.15±1.31 Placebo (N=11) 9.14±1.7 8.74±2.74 0.40±2.72 t -1.72 -0.62 -0.58 P 0.10 0.55 0.57 FG Normal GlucoVita (N=16) 9.13±1.05 7.37±2.14 1.76±2.67 Placebo (N=12) 8.65±0.93 6.94±1.74 1.71±2.02 t 1.25 0.57 0.06 P 0.22 0.58 0.96 Impaired GlucoVita (N=27) 7.57±1.71 7.34±2.06 0.18±1.24 Placebo (N=33) 7.68±1.65 7.58±2.23 0.20±1.75 t -0.26 -0.43 -0.05 P 0.79 0.67 0.96 2h-PG Normal GlucoVita (N=16) 6.37±0.81 6.24±1.7 0.05±1.40 Placebo (N=16) 6.30±0.85 6.88±1.54 -0.39±0.9 t 0.24 -1.12 1.05 P 0.81 0.27 0.30 Impaired GlucoVita (N=27) 9.20±1.02 8.01±1.99 1.19±2.23 Placebo (N=29) 8.85±0.99 7.70±2.34 1.15±2.12 t 1.33 0.53 0.08 P 0.19 0.60 0.94
, P<0.05 within-group comparison: preintervention versus postintervention.
+ , P<0.05 between-group comparison.
++ , P<0.01 between-group comparison.